Salicylic Acid

Salicylic Acid

SCHEMBL7115608

COc1cc(-c2cnc3[nH]cc(N)c3c2)ccc1O.O=C(O)c1ccccc1O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 6/20 0.56
GSK3B P49841 1/20 0.52
MAP3K11 Q16584 2/20 0.52
MAP4K1 Q92918 1/20 0.51
KIT P10721 7/20 0.49
AXL P30530 1/20 0.48
FYN P06241 1/20 0.47
NTRK1 P04629 1/20 0.47
DYRK1A Q13627 1/20 0.47
LRRK2 Q5S007 1/20 0.46
CAMKK2 Q96RR4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7111627 0.88 KIT (0.61) AAK1GSK3BMAP3K11KITNTRK1
SCHEMBL7115613 0.86 AAK1 (0.57) AAK1GSK3BMAP3K11MAP4K1KIT
SCHEMBL7119150 0.85 MAP3K11 (0.54) AAK1GSK3BMAP3K11KITNTRK1
SCHEMBL7113034 0.82 MAP3K11 (0.52) AAK1GSK3BMAP3K11KITNTRK1
SCHEMBL7118425 0.81 MAP3K11 (0.51) AAK1GSK3BMAP3K11MAP4K1KIT
SCHEMBL1516586 0.75 AAK1 (0.65) AAK1MAP3K11MAP4K1KITDYRK1A
SCHEMBL12762883 0.74 MAP4K1 (0.69) AAK1GSK3BMAP3K11MAP4K1KIT
SCHEMBL12763532 0.73 DYRK1A (0.73) AAK1MAP3K11KITDYRK1A
SCHEMBL1516821 0.73 KIT (0.70) AAK1MAP3K11KITDYRK1ALRRK2
SCHEMBL7112799 0.72 KIT (0.53) AAK1MAP3K11KITDYRK1ALRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003028724-A1 CHK1 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-04-10 WO disclosed